Skip to main content
Log in

Expression of Syndecan-1 in Inflammatory Bowel Disease and a Possible Mechanism of Heparin Therapy

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Heparin apparently aids healing in ulcerativecolitis although its mechanism of action is unknown. Thepurpose of this study was to investigate the hypothesisthat heparin functions as a coreceptor molecule for basic fibroblast growth factor, a roleusually performed by heparan sulfate chains onsyndecan-1. A marked reduction of syndecan-1immunostaining was found in reparative epithelium frominflammatory bowel disease patients. Removal of heparansulfate on gastrointestinal epithelial cells in vitroreduced the proliferative response to basic fibroblastgrowth factor. The response to basic fibroblast growth factor was completely restored by the additionof heparin. Loss of syndecan-1 expression occurs in theregenerative mucosa in inflammatory bowel disease.Although this may facilitate tissue motility, its loss probably adversely affects the ability ofcells to bind basic fibroblast growth factor. Thepresent data show that heparin may substitute the lossof functional activity of syndecan-1 in the binding of basic fibroblast growth factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Gumbiner BM: Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84:345–357, 1996

    Google Scholar 

  2. Dippold W, Wittig B, Schwaeble W, Mayet W, Meyerzum Büshenfelde K-H: Expression of intercellular adhesion mole-cule-1 (ICAM-1, CD54) in colonic epithelial cells. Gut 34:1593–1597, 1993

    Google Scholar 

  3. Jones SC, Banks RE, Haidar A, Gearing AJH, Hemingway IK, Ibbotson SH, Dixon MF, Axon ATR: Adhesion molecules in inflammatory bowel disease. Gut 36:724–730, 1995

    Google Scholar 

  4. Koizumi M, King N, Lobb R, Benjamin C, Podolsky D: Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103:840–847, 1992

    Google Scholar 

  5. Jankowski J, Bedford F, Boulton R, Cruickshank N, Hall C, Elder J, Allan R, Forbes A, Kim Y, Wright N, Sanders D: Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Lab Invest 78:155–167, 1998

    Google Scholar 

  6. Rosenberg W, Prince C, Kaklamanis L, Fox S, Jackson D, Simmons D, Chapman R, Trowell J, Jewell D, Bell J: Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 345:1205–1209, 1995

    Google Scholar 

  7. Dogan A, Wang Z, Spencer J: E-cadherin expression in intestinal epithelium. J Clin Pathol 48:143–146, 1995

    Google Scholar 

  8. Hanby A, Chinery R, Poulsom R, Playford R, Pignatelli M: Down regulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am J Pathol 148:723–729, 1996

    Google Scholar 

  9. Hynes R: Integrins, a family of cell surfacere ceptors. Cell 48:549–555, 1987

    Google Scholar 

  10. Ruoslahti E: Proteoglycans in cell regulation. J Biol Chem 264:13369–13372, 1989

    Google Scholar 

  11. Bernfield M, Hinkes M, Gallo R: Developmental expression of syndecans: Possible function and regulation. Development Suppl:205–212, 1993

  12. Saunders S, Jalkanen M, O'Farrell S, Bernfield M: Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol 108:1547–1556, 1989

    Google Scholar 

  13. Sanderson R, Bernfield M: Molecular polymorphism of a cell surface proteoglycan: Distinct structures on simple and strati-fied epithelia. Proc Natl Acad Sci USA 85:9562–9566, 1988

    Google Scholar 

  14. Sanderson R, Lalor P, Bernfield M: B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1:27–35, 1989

    Google Scholar 

  15. Kato M, Bernfield M: Polymorphism of syndecan: a distinctive form on mesenchymal cells. J Cell Biol 109:320a, 1989

    Google Scholar 

  16. Bernfield M, Kokenyesi R, Kato M, Hinkes M, Spring J, Gallo R, Lose E: Biology of the syndecans: A family of transmembrane heparan sulphate proteoglycans. Annu Rev Cell Biol 8:365–393, 1992

    Google Scholar 

  17. Hayashi K, Hayashi M, Jalkanen M, Firestone J, Trelstad R, Bernfield M: Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscope study. J Histochem Cytochem 35:1079–1088, 1987

    Google Scholar 

  18. Kato M, Saunders S, Nguyen H, Bernfield M: Loss of cell surface synde can-1 causes epithelial cells to transform into anchorage-independent me senchyme-like cells. Mol Biol Cell 6:559–576, 1995

    Google Scholar 

  19. Day R, Hao X, Ilyas M, Daszak P, Talbot I, Forbes A: Changes in the expression of syndecan-1 in the colorectal adenomacarcinoma sequence. Virchows Arch 434:121–125, 1999

    Google Scholar 

  20. Bhora FY, Dunkin BJ, Batzri S, Aly HM, Bass BL, Sidawy AN, Harmon JW: Effect of growth factors on cell proliferation and epithelization in human skin. J Surg Res 59:236–244, 1995

    Google Scholar 

  21. New BA, Yeoman LC: Identification of basic fibroblast growth factor sensitivity and receptor ligand expression in human colon tumour cell lines. J Cell Physiol 150:320–326, 1992

    Google Scholar 

  22. Rapraeger A, Krufka A, Olwin B: Requirement of heparan sulfate for bFGF-mediated fibroblast growth factor and myoblast differentiation. Science 252:1705–1708, 1991

    Google Scholar 

  23. Steinfeld R, Van Den Berghe H, David G: Stimulation of fibroblast growth factor receptor-1 occupancy and signalling by cell surface-associated syndecans and glypican. J Cell Biol 133:405–416, 1996

    Google Scholar 

  24. Yayon A, Klagsbrun M, Esko J, Leder P, Ornitz D: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841–848, 1991

    Google Scholar 

  25. Gaffney P, O'Leary J, Doyle C, Gaffney A, Hogan J, Smew F, Annis P: Response to heparin in patients with ulcerative colitis. Lancet 337:238–239, 1991

    Google Scholar 

  26. Gaffney P, Doyle C, Gaffney A, Hogan J, Hayes D, Annis P: Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 90:220–223, 1995

    Google Scholar 

  27. Talbot I, Price A: Biopsy Pathology in Colorectal Disease. London, Chapman and Hall, 1987

  28. Norton A, Jordan S, Yeomans P: Brief high-temperature heat denaturation (pre ssure cooking): A simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173:371–379, 1994

    Google Scholar 

  29. Wijdenes J, Vooijs W, Clément C, Post J, Morard F, Vita N, Laurent P, Sun R, Klein B, Dore J: A plasmocyte selective monoclonal antibody (B-B4) recognizes synde can-1. Br J Haematol 94:318–323, 1996

    Google Scholar 

  30. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytoxicity assays. J Immunol Methods 65:56–63, 1983

    Google Scholar 

  31. Kainulainen V, Nelimarkka L, Järveläinen H, Laato M, Jalkanen M, Elenius K: Suppression of synde can-1 expression in endothelial cells by tumour necrosis factor-α. J Biol Chem 271:18759–18766, 1996

    Google Scholar 

  32. Murch S, MacDonald T, Walker-Smith J, Levin M, Lionetti P, Klein N: Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet 341:711–714, 1993

    Google Scholar 

  33. Szabo S, Kusstatscher S, Sakoulas G, Sandor Z, Vincze Á, Judus M: Growth factors: New “endogenous drugs” for ulcer healing. Scand J Gastroenterol 30( suppl 210):15–18, 1995

    Google Scholar 

  34. Szabo S, Folkman J, Vattay P, Morales R, Pinkus G, Kato K: Accelerated healing of duodenal-ulcers by oral-administration of a mute in of basic fibroblast growth factor in rats. Gastroenterology 106:1106–1111, 1994

    Google Scholar 

  35. Bousvaros A, Zurakowski D, Fishman S, Keogh K, Law T, Sun C, Leichtner A: Serum basic fibroblast growth factor in pediatric Crohn's disease– implications for wound healing. Dig Dis Sci 42:378–386, 1997

    Google Scholar 

  36. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T, Nagura H: Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 68:520–527, 1993

    Google Scholar 

  37. Klagsbrun M, Baird A: A dual receptor system is required for basic fibroblast growth factor activity. Cell 67:229–231, 1991

    Google Scholar 

  38. Dignass A, Tsunekawa S, Podolsky D: Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroente rology 106:1254–1262, 1994

    Google Scholar 

  39. Sanderson I, Leung K, Pearce F, Walker-Smith J: Lamina propria mast cells in biopsies from children with Crohn's disease. J Clin Pathol 39:279–283, 1986

    Google Scholar 

  40. King T, Biddle W, Bhatia P, Moore J, Miner P: Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig Dis Sci 37:490–495, 1992 Please add symbol.

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Day, R., Ilyas, M., Daszak, P. et al. Expression of Syndecan-1 in Inflammatory Bowel Disease and a Possible Mechanism of Heparin Therapy. Dig Dis Sci 44, 2508–2515 (1999). https://doi.org/10.1023/A:1026647308089

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026647308089

Navigation